[(3R)-1-[7-(2-Butynyl)-2,3,6,7-tetrahydro-3-methy1-1-[(4-methy1-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yll-3-piperidinyllcarbamicacid 1,1-dimethylethyl ester

医药中间体 · — · —

医药中间体Confidentiality：公开

INN / Generic Name: [(3R)-1-[7-(2-Butynyl)-2,3,6,7-tetrahydro-3-methy1-1-[(4-methy1-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yll-3-piperidinyllcarbamicacid 1,1-dimethylethyl ester
CAS No.: 668273-75-4
Dosage Form: —
Strength: —
Therapy Area: Pharmaceutical Intermediates
Indication: API: Linagliptin
Current Status: 官方中间体目录（API: Linagliptin）
GMP Certification: —
CEP: No
DMF Type: —
Stability Data: —
BE Required: Not required / waivable
Registration Pathway: FSO 供货（非注册物质）
MOQ: 询价
Lead Time: 询价
Price Range: 询价

Registrable Markets

Global

Process / Sequence / Exact Price